Britannia Life Sciences Inc. (BLAB)
CSE
0.0650
-0.0050 (-7.14%)
Real-time Data
01:30 PM
Day's Range
0.06500.0650
52 wk Range
0.06000.1400
Financial Statements - BLAB - Britannia Life Sciences Inc.
Revenue
369.27K▼ 95.1%
Net Income
7.50M▲ 270.7%Net Margin 2032.8%
EBITDA
-4.05M▲ 12.3%
Free Cash Flow
-2.61M▼ 249.3%
Income Statement
| Period Ending | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Sales | 369.27K | 7.56M | 6.40M | 7.29M | 1.42M |
| Cost of Goods | 341.95K | 2.71M | 1.76M | 2.03M | 253.03K |
| Gross Profit | 27.32K | 4.85M | 4.63M | 5.26M | 1.17M |
 Operating Expense | - | - | - | - | - |
| Operating Income | -2.02M | -3.98M | 994.09K | -8.35M | 282.56K |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | -2.43M | 805.11K | 5.71M | -2.60M | 476.37K |
| Pre Tax Income | -4.56M | -4.46M | 5.85M | -13.27M | 400.63K |
| Income Tax | 0 | -67.35K | 19.86K | 711.59K | 257.66K |
| Net Income | 7.50M | -4.39M | 5.83M | -13.98M | 142.97K |
| EPS Basic | 0.04 | -0.03 | 0.03 | -0.14 | -0.002 |
| EPS Diluted | 0.04 | -0.03 | 0.03 | -0.14 | -0.002 |
| Basic Shares Outstanding | 162.25M | 162.25M | 162.14M | 109.50M | 77.62M |
| Diluted Shares Outstanding | 162.25M | 162.25M | 162.14M | 109.50M | 77.62M |
| Ebit | -4.45M | -3.18M | 6.71M | -10.96M | 758.93K |
| Ebitda | -4.05M | -4.61M | 1.20M | -8.16M | 318.01K |
| Net Income Continuous Operations | -4.56M | -4.39M | 5.83M | -13.98M | 142.97K |
| Minority Interests | -113.97K | -369.32K | -754.30K | -1.47M | -300.13K |
| Preferred Stock Dividends | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
